irumamycin: from Streptomyces subflavus; macrolide antibiotic with sugar moiety [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 5385011 |
| SCHEMBL ID | 2712031 |
| MeSH ID | M0106613 |
| Synonym |
|---|
| nsc-374130 |
| NSC374130 , |
| 81604-73-1 |
| irumamycin |
| SCHEMBL2712031 |
| [6-[[(9e,15e)-1,7-dihydroxy-6,8,16,18-tetramethyl-5-[4-(3-methyl-3-propanoyloxiran-2-yl)pentan-2-yl]-3-oxo-4,21-dioxabicyclo[15.3.1]henicosa-9,15,18-trien-11-yl]oxy]-3-hydroxy-2-methyloxan-4-yl] carbamate |
| VROYMKJUVCKXBU-HDTXIYAQSA-N |
| DTXSID201318355 |
Irumamycin is a new 20-membered macrolide antibiotic isolated from a culture broth of a soil isolate.
| Excerpt | Reference | Relevance |
|---|---|---|
| "Irumamycin is a new 20-membered macrolide antibiotic isolated from a culture broth of a soil isolate which was named Streptomyces subflavus subsp. " | ( Irumamycin, an antifungal 20-membered macrolide produced by a Streptomyces. Taxonomy, fermentation and biological properties. Chia, I; Inoue, M; Iwai, Y; Omura, S; Takahashi, Y; Tanaka, Y, 1984) | 3.15 |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 3 (60.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 5 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||